Abdominal aorta vascular prosthesis KARDIOZIS

synthetic

KARDIOZIS is the first endovascular prosthesis for treating the Abdominal Aortic Aneurism that can prevent endoleaks and the recurrence of the disease. Principle : Kardiozis employs a disruptive approach that prevents risk of post-EVAR type-II endoleaks seen in 20 to 40% of cases while more effectively reducing aortic aneurysm size. The Kardiozis endoprosthesis includes external thrombogenic fibers which, upon implantation, produce a blood coagulation effect around the device that prevents growth of the aneurysm sac and nourishment by lateral arterioles. This can eliminate the risk of early or late endoleaks, thereby offering patients and surgeons alike secure and effective therapy through fast and minimally invasive surgery.